Hemophagocytic lymphohistiocytosis

American Journal of Clinical Pathology

Volumn 139, Issue 6, 2013, Pages 713-727

  Rosado, Flavia G N ^a   Kim, Annette S ^b  

^a MAYO CLINIC   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired; Genetic; Hemophagocytic lymphohistiocytosis; Hypercytokinemia; Macrophage activation syndrome; Perforin

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; GAMMA INTERFERON; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FERRITIN; PERFORIN;

BACTERIAL STRAIN; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOKINE STORM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS INFECTION; FLOW CYTOMETRY; FUNGAL STRAIN; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HEMOPHAGOCYTIC SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INCIDENCE; MACROPHAGE ACTIVATION SYNDROME; NATURAL KILLER T CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T LYMPHOCYTE ACTIVATION; VIRUS STRAIN; ACQUIRED; ADOLESCENT; BLOOD; CHILD; GENETIC; GENETICS; MIDDLE AGED; PATHOLOGY;

ACQUIRED; GENETIC; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HYPERCYTOKINEMIA; MACROPHAGE ACTIVATION SYNDROME; PERFORIN;

ADOLESCENT; CHILD; CYTOKINES; EARLY DIAGNOSIS; EPSTEIN-BARR VIRUS INFECTIONS; FERRITINS; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MACROPHAGE ACTIVATION SYNDROME; MIDDLE AGED; PERFORIN;

MLCS; MLOWN;

EID: 84878384497     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP4ZDKJ4ICOUAT     Document Type: Review

References (139)

1. Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis. Arch Dis Child. 1952; 27: 519-525.
2. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012; 63: 233-246.
3. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991; 18: 29-33.
4. Larroche C, Scieux C, Honderlick P, et al. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult. Eur J Clin Microbiol Infect Dis. 2002; 21:739-742. (Pubitemid 35477928)
5. Allen M, De Fusco C, Legrand F, et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica. 2001;86:499-503. (Pubitemid 33638978)
6. Clementi R, Emmi L, Maccario R, et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood. 2002;100:2266-2267. (Pubitemid 35001269)
7. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med. 2006;38:20-31. (Pubitemid 43177784)
8. Arico M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia. 1996;10:197-203. (Pubitemid 26102881)
9. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983;140:221-230. (Pubitemid 13026976)
10. Gholam C, Grigoriadou S, Gilmour KC, et al. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol. 2011; 163: 271-283.
11. Freeman HR, Ramanan AV. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child. 2011; 96: 688-693.
12. Niece JA, Rogers ZR, Ahmad N, et al. Hemophagocytic lymphohistiocytosis in Texas: observations on ethnicity and race. Pediatr Blood Cancer. 2010; 54: 424-428.
13. Henter JI, Elinder G, Soder O, et al. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991; 80: 428-435.
14. Ishii E, Ohga S, Tanimura M, et al. Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group. Med Pediatr Oncol. 1998;30:276-283. (Pubitemid 28175623)
15. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58-65. (Pubitemid 47204491)
16. Gurgey A, Gogus S, Ozyurek E, et al. Primary hemophagocytic lymphohistiocytosis in Turkish children. Pediatr Hematol Oncol. 2003;20:367-371. (Pubitemid 36869792)
17. Chen RL, Su IJ, Lin KH, et al. Fulminant childhood hemophagocytic syndrome mimicking histiocytic medullary reticulosis: an atypical form of Epstein-Barr virus infection. Am J Clin Pathol. 1991; 96: 171-176.
18. Parodi A, Davi S, Pringe AB, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009; 60: 3388-3399.
19. Deane S, Selmi C, Teuber SS, et al. Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol. 2010; 153: 109-120.
20. Schleinitz N, Bernit E, Harle JR. Severe hemophagocytic syndrome after intravesical BCG instillation. Am J Med. 2002;112:593-594. (Pubitemid 34518327)
21. Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010; 36: 1695-1702.
22. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124-131. (Pubitemid 44958267)
23. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009; 10: 387-392.
24. Morrell DS, Pepping MA, Scott JP, et al. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol. 2002;138:1208-1212. (Pubitemid 35025694)
25. Shinoda J, Murase S, Takenaka K, et al. Isolated central nervous system hemophagocytic lymphohistiocytosis: case report. Neurosurgery. 2005;56:187. (Pubitemid 40054009)
26. Chong KW, Lee JH, Choong CT, et al. Hemophagocytic lymphohistiocytosis with isolated central nervous system reactivation and optic nerve involvement. J Child Neurol. 2012; 27: 1336-1339.
27. Gurgey A, Aytac S, Balta G, et al. Central nervous system involvement in Turkish children with primary hemophagocytic lymphohistiocytosis. J Child Neurol. 2008; 23: 1293-1299.
28. Henter JI, Elinder G. Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet. 1992; 339: 104-107.
29. Rooms L, Fitzgerald N, McClain KL. Hemophagocytic lymphohistiocytosis masquerading as child abuse: presentation of three cases and review of central nervous system findings in hemophagocytic lymphohistiocytosis. Pediatrics. 2003; 111( pt 1): e636-e640.
30. Suzuki N, Morimoto A, Ohga S, et al. Characteristics of hemophagocytic lymphohistiocytosis in neonates: a nationwide survey in Japan. J Pediatr. 2009; 155: 235-238.e1.
31. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009; 221: 278-285.
32. Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50:1227-1235. (Pubitemid 351555548)
33. Schneider EM, Lorenz I, Muller-Rosenberger M, et al. Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood. 2002; 100: 2891-2898.
34. Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:965-971. (Pubitemid 46399444)
35. Lai S, Merritt BY, Chen L, et al. Hemophagocytic lymphohistiocytosis associated with influenza A (H1N1) infection in a patient with chronic lymphocytic leukemia: an autopsy case report and review of the literature. Ann Diagn Pathol. 2012; 16: 477-484.
36. Foucar K, Reichard K, Czuchlewski D. Bone Marrow Pathology. 3rd ed. Chicago, IL: American Society for Clinical Pathology; 2010.
37. Hsi ED. Hematopathology: A Volume in Foundations in Diagnostic Pathology Series. London, UK: Churchill Livingstone; 2007.
38. Aronson IK, Worobec SM. Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: an overview. Dermatol Ther. 2010; 23: 389-402.
39. de Kerguenec C, Hillaire S, Molinie V, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol. 2001;96:852-857. (Pubitemid 32240744)
40. Chen JH, Fleming MD, Pinkus GS, et al. Pathology of the liver in familial hemophagocytic lymphohistiocytosis. Am J Surg Pathol. 2010; 34: 852-867.
41. Kuwata K, Yamada S, Kinuwaki E, et al. Peripheral hemophagocytosis: an early indicator of advanced systemic inflammatory response syndrome/ hemophagocytic syndrome. Shock. 2006; 25: 344-350.
42. Strauss R, Neureiter D, Westenburger B, et al. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients - a postmortem clinicopathologic analysis. Crit Care Med. 2004;32:1316-1321. (Pubitemid 38738586)
43. Puente J, Carvajal T, Parra S, et al. In vitro studies of natural killer cell activity in septic shock patients: response to a challenge with alpha-interferon and interleukin-2. Int J Clin Pharmacol Ther Toxicol. 1993;31:271-275. (Pubitemid 23187443)
44. von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007;196:1288-1295. (Pubitemid 351412000)
45. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010; 6: 137-154.
46. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004;124:4-14. (Pubitemid 38021618)
47. Ravelli A, Grom AA, Behrens EM, et al. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012; 13: 289-298.
48. Trizzino A, zur Stadt U, Ueda I, et al. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations. J Med Genet. 2008;45:15-21. (Pubitemid 351158153)
49. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999;286:1957-1959. (Pubitemid 129515904)
50. Menasche G, Feldmann J, Fischer A, et al. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev. 2005;203:165-179. (Pubitemid 40179701)
51. Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al. Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis. Am J Hum Genet. 2001;68:590-597. (Pubitemid 32202754)
52. Feldmann J, Callebaut I, Raposo G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell. 2003;115:461-473. (Pubitemid 37456808)
53. zur Stadt U, Schmidt S, Kasper B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet. 2005;14:827-834. (Pubitemid 40403278)
54. zur Stadt U, Rohr J, Seifert W, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009; 85: 482-492.
55. Ohadi M, Lalloz MR, Sham P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. Am J Hum Genet. 1999;64:165-171. (Pubitemid 30428969)
56. Cetica V, Pende D, Griffiths GM, et al. Molecular basis of familial hemophagocytic lymphohistiocytosis. Haematologica. 2010; 95: 538-541.
57. Johnson TS, Villanueva J, Filipovich AH, et al. Contemporary diagnostic methods for hemophagocytic lymphohistiocytic disorders. J Immunol Methods. 2011; 364: 1-13.
58. Garcia-Astudillo LA, Fontalba A, Mazorra F, et al. Severe course of community-acquired pneumonia in an adult patient who is heterozygous for Q481P in the perforin gene: are carriers of the mutation free of risk? J Investig Allergol Clin Immunol. 2009; 19: 311-316.
59. zur Stadt U, Pruggmayer M, Jung H, et al. Prenatal diagnosis of perforin gene mutations in familial hemophagocytic lymphohistiocytosis (FHLH). Prenat Diagn. 2002;22:80-81. (Pubitemid 34146059)
60. Kogawa K, Lee SM, Villanueva J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood. 2002; 99: 61-66.
61. Marcenaro S, Gallo F, Martini S, et al. Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood. 2006;108:2316-2323. (Pubitemid 44497515)
62. Tabata Y, Villanueva J, Lee SM, et al. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members. Blood. 2005; 105: 3066-3071.
63. Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol. 1999;2:360-366. (Pubitemid 29290852)
64. Titze U, Janka G, Schneider EM, et al. Hemophagocytic lymphohistiocytosis and Kawasaki disease: combined manifestation and differential diagnosis. Pediatr Blood Cancer. 2009; 53: 493-495.
65. Arico M, Allen M, Brusa S, et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol. 2002;119:180-188. (Pubitemid 35176519)
66. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004;50:689-698. (Pubitemid 38326166)
67. Lichtenheld MG, Olsen KJ, Lu P, et al. Structure and function of human perforin. Nature. 1988; 335: 448-451.
68. Chuang HC, Lay JD, Hsieh WC, et al. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci. 2007; 98: 1281-1287.
69. Jordan MB, Hildeman D, Kappler J, et al. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood. 2004;104:735-743. (Pubitemid 38970567)
70. Arico M, Danesino C, Pende D, et al. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol. 2001;114:761-769. (Pubitemid 32953731)
71. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004;3:69-75. (Pubitemid 38293367)
72. Schneider EM, Lorenz I, Walther P, et al. Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? J Pediatr Hematol Oncol. 2003;25:680-683. (Pubitemid 37087502)
73. Selleri C, Sato T, Anderson S, et al. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol. 1995; 165: 538-546.
74. Otterbein LE, Soares MP, Yamashita K, et al. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449-455. (Pubitemid 36928103)
75. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166:95-109. (Pubitemid 46025500)
76. Ueda I, Morimoto A, Inaba T, et al. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol. 2003;121:503-510. (Pubitemid 36628346)
77. Ishii E, Ueda I, Shirakawa R, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood. 2005;105:3442-3448. (Pubitemid 40628184)
78. Janka G, zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program. 2005: 82-88.
79. Stinchcombe J, Bossi G, Griffiths GM. Linking albinism and immunity: the secrets of secretory lysosomes. Science. 2004;305:55-59. (Pubitemid 38869367)
80. Menasche G, Pastural E, Feldmann J, et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet. 2000;25:173-176. (Pubitemid 30394987)
81. Meeths M, Bryceson YT, Rudd E, et al. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer. 2010; 54: 563-572.
82. Nagle DL, Karim MA, Woolf EA, et al. Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet. 1996;14:307-311. (Pubitemid 126449765)
83. Enders A, Zieger B, Schwarz K, et al. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II. Blood. 2006;108:81-87. (Pubitemid 43990615)
84. Dupre L, Andolfi G, Tangye SG, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells. Blood. 2005;105:4383-4389. (Pubitemid 40720785)
85. Pasic S, Micic D, Kuzmanovic M. Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis in Wiskott-Aldrich syndrome. Acta Paediatr. 2003;92:859-861. (Pubitemid 37098303)
86. Arico M, Bettinelli A, Maccario R, et al. Hemophagocytic lymphohistiocytosis in a patient with deletion of 22q11.2. Am J Med Genet. 1999; 87: 329-330.
87. Schmid I, Reiter K, Schuster F, et al. Allogeneic bone marrow transplantation for active Epstein-Barr virus-related lymphoproliferative disease and hemophagocytic lymphohistiocytosis in an infant with severe combined immunodeficiency syndrome. Bone Marrow Transplant. 2002;29:519-521. (Pubitemid 34428722)
88. Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 1979;44:993-1002. (Pubitemid 10242233)
89. Clementi R, Locatelli F, Dupre L, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood. 2005; 105: 4424-4428.
90. Nagafuji K, Nonami A, Kumano T, et al. Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica. 2007;92:978-981. (Pubitemid 350144246)
91. Karras A, Thervet E, Legendre C. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77:238-243. (Pubitemid 38155753)
92. Abdelkefi A, Ben Jamil W, Torjman L, et al. Hemophagocytic syndrome after hematopoietic stem cell transplantation: a prospective observational study. Int J Hematol. 2009; 89: 368-373.
93. Henter JI, Ehrnst A, Andersson J, et al. Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr. 1993;82:369-372. (Pubitemid 23142852)
94. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol. 2002;44:259-272. (Pubitemid 35435291)
95. Li CF, Ye H, Liu H, et al. Fatal HHV-8-associated hemophagocytic syndrome in an HIV-negative immunocompetent patient with plasmablastic variant of multicentric Castleman disease (plasmablastic microlymphoma). Am J Surg Pathol. 2006;30:123-127. (Pubitemid 43740219)
96. Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7:814-822. (Pubitemid 350152044)
97. Dutta U, Mittal S, Ratho RK, et al. Acute liver failure and severe hemophagocytosis secondary to parvovirus B19 infection. Indian J Gastroenterol. 2005;24:118-119. (Pubitemid 40980039)
98. Katsibardi K, Moschovi MA, Theodoridou M, et al. Enterovirus-associated hemophagocytic syndrome in children with malignancy: report of three cases and review of the literature. Eur J Pediatr. 2008;167:97-102. (Pubitemid 350159826)
99. Sun HY, Chen MY, Fang CT, et al. Hemophagocytic lymphohistiocytosis: an unusual initial presentation of acute HIV infection. J Acquir Immune Defic Syndr. 2004; 37: 1539-1540.
100. Niedt GW, Schinella RA. Acquired immunodeficiency syndrome: clinicopathologic study of 56 autopsies. Arch Pathol Lab Med. 1985;109:727-734. (Pubitemid 16237468)
101. Sailler L, Duchayne E, Marchou B, et al. Etiological aspects of reactive hemophagocytoses: retrospective study in 99 patients [in French]. Rev Med Interne. 1997;18:855-864. (Pubitemid 27515032)
102. Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy-associated hemophagocytic syndromes: secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998;12:435-444. (Pubitemid 28175891)
103. Brastianos PK, Swanson JW, Torbenson M, et al. Tuberculosis-associated haemophagocytic syndrome. Lancet Infect Dis. 2006; 6: 447-454.
104. Numata K, Tsutsumi H, Wakai S, et al. A child case of haemophagocytic syndrome associated with cryptococcal meningoencephalitis. J Infect. 1998;36:118-119. (Pubitemid 128645639)
105. Koduri PR, Chundi V, DeMarais P, et al. Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis. 1995;21:1463-1465. (Pubitemid 26066639)
106. Fardet L, Lambotte O, Meynard JL, et al. Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS. 2010; 24: 1299-1306.
107. Sotoca Fernandez JV, Garcia Villaescusa L, Lillo Lillo M, et al. Hemophagocytic syndrome secondary to visceral leishmaniasis [in Spanish]. An Pediatr (Barc). 2008;69:46-48. (Pubitemid 351956983)
108. Kawaguchi H, Miyashita T, Herbst H, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest. 1993;92:1444-1450. (Pubitemid 23273923)
109. Imashuku S, Teramura T, Tauchi H, et al. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica. 2004;89:183-188. (Pubitemid 38796492)
110. Rickinson AB. Epstein-Barr virus in action in vivo. N Engl J Med. 1998;338:1461-1463. (Pubitemid 28221990)
111. Yoneda N, Tatsumi E, Kawanishi M, et al. Detection of Epstein-Barr virus genome in benign polyclonal proliferative T cells of a young male patient. Blood. 1990;76:172-177. (Pubitemid 20220807)
112. Su IJ, Chen RL, Lin DT, et al. Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol. 1994; 144: 1219-1225.
113. Kasahara Y, Yachie A, Takei K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001; 98: 1882-1888.
114. Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol. 2002;44:283-294. (Pubitemid 35435293)
115. Chan LC, Srivastava G, Pittaluga S, et al. Detection of clonal Epstein-Barr virus in malignant proliferation of peripheral blood CD3+ CD8+ T cells. Leukemia. 1992; 6: 952-956.
116. Kanegane H, Bhatia K, Gutierrez M, et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood. 1998;91:2085-2091. (Pubitemid 28185512)
117. Chen JS, Tzeng CC, Tsao CJ, et al. Clonal karyotype abnormalities in EBV-associated hemophagocytic syndrome. Haematologica. 1997; 82: 572-576.
118. Lay JD, Tsao CJ, Chen JY, et al. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997; 100: 1969-1979.
119. Cho HS, Park YN, Lyu CJ, et al. EBV-elicited familial hemophagocytic lymphohistiocytosis. Yonsei Med J. 1997; 38: 245-248.
120. Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 1998;395:462-469. (Pubitemid 28462434)
121. Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet. 1998;20:129-135. (Pubitemid 28455444)
122. Jager M, Benninger-Doring G, Prang N, et al. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis. Int J Cancer. 1998;76:694-701. (Pubitemid 28243943)
123. Sharifi R, Sinclair JC, Gilmour KC, et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood. 2004;103:3821-3827. (Pubitemid 38596301)
124. Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood. 2005; 106: 3090-3096.
125. Sakai T, Shiraki K, Deguchi M, et al. Hepatocellular carcinoma associated with hemophagocytic syndrome. Hepatogastroenterology. 2001;48:1464-1466. (Pubitemid 33010448)
126. Tatsuta H, Hoso T, Takagi T, et al. Small cell lung cancer presenting as hemophagocytic syndrome [in Japanese]. Nihon Naika Gakkai Zasshi. 2005; 94: 756-758.
127. Koizumi K, Haseyama Y, Machino R, et al. The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow. J Urol. 2002; 168: 1101-1102.
128. Menard F, Besson C, Rince P, et al. Hodgkin lymphoma-associated hemophagocytic syndrome: a disorder strongly correlated with Epstein-Barr virus. Clin Infect Dis. 2008; 47: 531-534.
129. Yamazaki S, Nakamura F, Nasu R, et al. Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukaemia. Br J Haematol. 2011; 153: 669-672.
130. Recalcati S, Invernizzi P, Arosio P, et al. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun. 2008; 30: 84-89.
131. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol. 2007;19:477-481. (Pubitemid 47344241)
132. Tabata R, Tabata C, Terada M, et al. Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases. Clin Rheumatol. 2009; 28: 461-464.
133. Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol. 2004;50:157-174. (Pubitemid 38638742)
134. Horne A, Janka G, Maarten Egeler R, et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol. 2005;129:622-630. (Pubitemid 40825824)
135. Cooper N, Rao K, Gilmour K, et al. Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood. 2006;107:1233-1236. (Pubitemid 43156331)
136. Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics. 2006;117:e743-750. (Pubitemid 46071479)
137. Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002; 100: 2367-2373.
138. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19:2665-2673. (Pubitemid 32441371)
139. Raschke RA, Garcia-Orr R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest. 2011; 140: 933-938.